- Home
- PTGX vs MPW Comparison
PTGX vs MPW Comparison
Compare PTGX & MPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- MPW
- Stock Information
- Founded
- PTGX 2006
- MPW 2003
- Country
- PTGX United States
- MPW United States
- Employees
- PTGX N/A
- MPW N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- MPW Real Estate Investment Trusts
- Sector
- PTGX Health Care
- MPW Real Estate
- Exchange
- PTGX Nasdaq
- MPW Nasdaq
- Market Cap
- PTGX 2.7B
- MPW 2.4B
- IPO Year
- PTGX 2016
- MPW 2005
- Fundamental
- Price
- PTGX $37.94
- MPW $4.32
- Analyst Decision
- PTGX Strong Buy
- MPW Hold
- Analyst Count
- PTGX 8
- MPW 6
- Target Price
- PTGX $54.63
- MPW $4.92
- AVG Volume (30 Days)
- PTGX 638.0K
- MPW 13.8M
- Earning Date
- PTGX 02-25-2025
- MPW 02-19-2025
- Dividend Yield
- PTGX N/A
- MPW 7.44%
- EPS Growth
- PTGX N/A
- MPW N/A
- EPS
- PTGX 2.68
- MPW N/A
- Revenue
- PTGX $323,795,000.00
- MPW $660,172,000.00
- Revenue This Year
- PTGX $441.08
- MPW N/A
- Revenue Next Year
- PTGX N/A
- MPW N/A
- P/E Ratio
- PTGX $14.23
- MPW N/A
- Revenue Growth
- PTGX 125.73
- MPW N/A
- 52 Week Low
- PTGX $24.21
- MPW $3.08
- 52 Week High
- PTGX $48.89
- MPW $6.55
- Technical
- Relative Strength Index (RSI)
- PTGX 47.00
- MPW 60.28
- Support Level
- PTGX $35.03
- MPW $3.93
- Resistance Level
- PTGX $38.50
- MPW $4.41
- Average True Range (ATR)
- PTGX 1.55
- MPW 0.22
- MACD
- PTGX 0.15
- MPW 0.06
- Stochastic Oscillator
- PTGX 63.65
- MPW 88.89
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.